Original news and analysis on international IP policy
The Third annual United Nations Multi-stakeholder Forum on Science, Technology and Innovation for the Sustainable Development Goals opened with Marie Chatardová, president of the Economic and Social Council, stating that “STI is shaping the trajectory of our society, helping the world address global challenges and achieve Sustainable Development Goals.”
Frederick Abbott writes: On 20 May 2018, US Treasury Secretary Mnuchin announced that the US and China were “putting the trade war on hold” while the two countries seek to “execute the framework” of a broad agreement intended to reduce the US trade deficit in goods with China. According to the joint statement issued on 19 May 2018, “Both sides attach paramount importance to intellectual property protections, and agreed to strengthen cooperation. China will advance relevant amendments to its laws and regulations in this area, including the Patent Law.”
A new “virtual assistant” used by the Australian Intellectual Property Office may be able in the future to read the facial expressions of trademark filers and provide them with solutions - with empathy.
Next week, the World Trade Organization intellectual property committee is invited to discuss two distinct aspects of intellectual property protection. One group of countries is proposing to explore the value of IP and its role in improving lives in a persistent agenda item on IP and innovation. Another group of countries is pushing for a more recent agenda on IP and the public interest and next week is suggesting to discuss how to use competition laws against the abuse of IP rights.
The Medicines Patent Pool announced this week that its Board agreed on the extension of the MPP mandate to patented medicines on the World Health Organization Essential Medicines List. The decision follows an extensive feasibility study. During a side event held on the margins of the annual World Health Assembly, Patent Pool officials explained the findings of the study, while in the audience, a representative of the pharmaceutical industry suggested a cautious approach.
Ten years after the adoption of a World Health Organization plan of action meant to stimulate innovation for diseases that disproportionately affect developing countries, and with very little to show for it since, delegates at the World Health Assembly this week agreed to a number of recommendations to reinvigorate the effort. How to finance the implementation of those recommendations, however, is unclear.
On the side of this week’s World Health Assembly and hours before the Assembly agreed on preparing a roadmap on access to medicines, two civil society groups held an event on the same subject. The Brazilian ambassador, a senior official from the Netherlands, and a WHO assistant director general among others delivered their thoughts on the issue and the way forward. Key words were high prices, transparency, and trade flexibilities.
During a side event held alongside this week's World Health Assembly, public health advocates proposed that Switzerland use compulsory licensing as a way to decrease what they said are exorbitant drug prices.
Countries, organisations and foundations came together today alongside the annual World Health Assembly to launch the Global Antimicrobial Resistance and Development Hub (Global AMR R&D Hub).
In the wake of the annual intellectual property day this year focusing on women, the World Intellectual Property Organization Committee on Development and IP this week agreed to discuss women and IP at its next session, as the first topic under a new agenda. The committee also agreed to a new project on the role of women in innovation. In other areas, more discussions are foreseen on whether regular international conferences on IP and development can be approved, and on recommendations by an independent expert group on the implementation of the WIPO Development Agenda.